Pooled Safety Results from Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis through 1 Year

Ritchlin, CT, Rahman, P, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (13 more authors) (2021) Pooled Safety Results from Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis through 1 Year. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
  • Ritchlin, CT
  • Rahman, P
  • Helliwell, P ORCID logo https://orcid.org/0000-0002-4155-9105
  • Boehncke, WH
  • Mcinnes, I
  • Gottlieb, AB
  • Kafka, S
  • Kollmeier, A
  • Hsia, EC
  • Xu, XL
  • Shawi, M
  • Sheng, S
  • Agarwal, P
  • Zhou, B
  • Ramachandran, P
  • Mease, PJ
Dates:
  • Published: June 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 13 Oct 2021 13:28
Last Modified: 13 Oct 2021 13:28
Status: Published
Identification Number: 10.1136/annrheumdis-2021-eular.1334
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)